The Acting FDA Commissioner lays out his agenda for approving life-saving cancer drugs, innovative therapies and clinical trials. and managing product safety.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Washington Post Live","authorlink":""},"src":"https:\/\/www.podtrac.com\/pts\/redirect.mp3\/podcast.washpostpodcasts.com\/washpost-production\/5a21a2d9e4b0f49da26f53cf\/20190812\/5d0a8e7f46e0fb0008c967ad\/5d51b283cff47e00091711f1_1351620000001-300040_t_1565635207430_44100_128_2.mp3?awCollectionId=5a21a2d9e4b0","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202211\/61a778-ec5d-e979-3aff09_800.jpg"},"title":"Inside the FDA: The New Commissioner\u2019s Game Plan","link":"javascript:;","id":"item-332629"}]